No prognostic impact of isolated lymphovascular invasion after radical resection of rectal cancer—results of a multicenter observational study
- 95 Downloads
The prognostic impact of isolated lymphovascular invasion (LVI) after radical resection of rectal cancer is controversially discussed. However, it could be relevant to decide for an adjuvant treatment.
The aim of the analysis was, based on the data of an observational study, to determine the prognostic relevance of the isolated LVI.
Materials and methods
Patients after radical resection of rectal cancer with no hemangioinvasion were subdivided in three groups: I—no LVI, no lymph node metastases (LNM); II—positive LVI, no LNM; III—positive LNM. Five-year local recurrence rate, distant metastases-free and disease-free survival were determined uni- and multivariate.
Patients, n = 846, were studied (I, n = 471; II, n = 75; III, n = 300). The univariate comparison between the groups revealed the following 5-year results: local recurrence rate: 9.4 vs 10.0 vs 14.0%; distant metastases-free survival: 84.1 vs 82.5 vs 49.3%; disease-free survival: 83.2 vs 80.7 vs 45.5%. The differences between groups I and III were significant, but not between groups I and II. The determined higher disease-free survival rate in group II vs group III was significant (P = 0.041), but the differences in local recurrence rate and rate of distant metastases did not reach statistical significance. The multivariate analysis revealed no impact of the isolated LVI on the oncological outcome.
The isolated LVI has no independent prognostic impact on the local recurrence rate and long-term survival after radical resection of rectal cancer. Based on this finding, no indication for an adjuvant treatment in these patients can be derived.
KeywordsRectal cancer Lymphovascular invasion Lymph node metastasis 5-year local recurrence rate Disease-free survival
- 1.Wibe A, Syse A, Andersen E, Tretli S, Myrvold HE, Soreide O; on behalf of the Norwegian Rectal Cancer Group (2004) Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum 47:48–58PubMedCrossRefGoogle Scholar
- 2.Cecil TD, Sexton R, Moran BJ, Heald RJ (2004) Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer. Dis Colon Rectum 45:1145–1150Google Scholar
- 13.Celen O, Yildirim E, Berberoglu U (2004) Factors influencing outcome of surgery for stage I rectal cancer. Neoplasm 51:487–490Google Scholar
- 14.Marusch F, Koch A, Schmidt U, Meyer L, Steinert R, Pross M, Köckerling F, Bauer H, Schönleben K, Halbfass HJ, Scheele J, Gastinger I, Lippert H; Studiengruppe “Kolon/Rektum Karzinome (Primärtumor)” (2003) Importance of rectal extirpation for the therapy concept of low rectal cancers. Chirurg 74:341–352PubMedCrossRefGoogle Scholar
- 18.Rosenberg R, Friederichs J, Gertler R, Hoos A, Mueller J, Nahrig J, Nekarda H, Siewert JR (2004) Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer. Int J Colorectal Dis 19:430–437PubMedCrossRefGoogle Scholar
- 20.Charbit L, Peschaud F, Penna C (2005) Lymph nodes in rectal cancer. J Chir (Paris) 142:85–92Google Scholar
- 24.Mouta Carriera C, Nasser SM, di Tomaso E, Padera TP, Boucher Y, Tomarev SI, Jain RK (2001) LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res 61:8079–8084Google Scholar